Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enerside Energy S.A. | 9O8 | Nov 14, 2024 | 4.02 | +0.50 |
Enersize | 9H0 | Nov 14, 2024 | 0.00 | 0.00 |
EnerSys | FDN | Nov 14, 2024 | 91.85 | -0.70 |
Enertime | E0T | Nov 14, 2024 | 0.15 | 0.00 |
Engcon AB | 917 | Nov 14, 2024 | 10.00 | +0.20 |
Enghouse Systems Ltd | 3E4 | Nov 14, 2024 | 20.80 | +0.97 |
Engie | GZFB | Nov 14, 2024 | 15.10 | 0.00 |
Engie Brasil Energia S A American Depositary Receipts - Spon | 7TE1 | Nov 14, 2024 | 6.05 | -0.82 |
Engie EPS | 8XE | Nov 14, 2024 | 1.21 | 0.00 |
Engie SA | GZF | Nov 14, 2024 | 15.14 | -0.33 |
Engineer Gold Mines Ltd | 9EG0 | Nov 14, 2024 | 0.02 | 0.00 |
Enhabit | X34 | Nov 14, 2024 | 6.90 | 0.00 |
Eni ADR | ENI1 | Nov 14, 2024 | 27.20 | 0.00 |
Eni SpA | ENI | Nov 14, 2024 | 13.96 | +1.84 |
Eniro | EN8A | Nov 14, 2024 | 0.03 | +17.86 |
ENKA INSAAT (U.ADR)/4 TN1 | ENP | Nov 14, 2024 | 4.80 | +0.84 |
Enlivex Therapeutics Ltd. - Ordinary Shares | 1BT | Nov 14, 2024 | 1.08 | -0.92 |
ENN ENERGY | XGH | Nov 14, 2024 | 6.15 | -1.60 |
ENN ENERGY HLD.UNS.ADR/25 | XGH0 | Nov 14, 2024 | 24.40 | -1.61 |
ENNOGIE SOL.GRP. NAM. DK1 | B0W | Nov 14, 2024 | 0.85 | -2.51 |
Enochian Biosciences Inc | 2Q5 | Nov 14, 2024 | 0.53 | -2.93 |
Enogia S.A | 7BZ | Nov 14, 2024 | 1.53 | +0.66 |
Enova International, Inc. | 27E | Nov 14, 2024 | 97.00 | -0.51 |
ENOVIS CORP. | C520 | Nov 14, 2024 | 43.60 | -0.91 |
Enphase Energy, Inc. | E0P | Nov 14, 2024 | 62.71 | +11.98 |
EnPro Industries Inc | EP9 | Nov 14, 2024 | 154.00 | +0.65 |
EnQuest PLC | 3EQ | Nov 14, 2024 | 0.13 | -3.51 |
ENRG ELEMENTS LTD. | O9B | Nov 14, 2024 | 0.00 | 0.00 |
Enservco Corporation | A3O0 | Nov 14, 2024 | 0.11 | 0.00 |
Enstar Group Limited - Ordinary Shares | 48R | Nov 14, 2024 | 306.00 | +0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.